Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic.
Yi WangNantasit LuangasanatipWirichada Pan-NgumWanrudee IsaranuwatchaiJuthamas PrawjaengSompob SaralambaChristopher PainterJamaica Roanne BrionesYot TeerawattananonPublished in: The European journal of health economics : HEPAC : health economics in prevention and care (2022)
COVID-19 vaccines are good value for money even in a relatively low-incidence and low-mortality setting such as Thailand, if the appropriate groups are vaccinated. The preferred vaccination strategies depend on the type of vaccine efficacy. Social distancing measures should accompany a vaccination strategy.